Celyad

Manufacturing · Belgium · 11-50 Employees

View Company Info for Free

Overview

Headquarters

Rue André Dumont 9, Mont-Saint-Guibert, ...

Phone Number

+32 10394100

Revenue

<$5 Million

Stock Symbol

CYAD

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Celyad

Celyad is a clinical-stage biopharmaceutical company founded in 2007 and headquartered in Mont-Saint-Guibert, Belgium, with additional operations in New York. The company specializes in the development of CAR-T cell-based therapies targeting cancer. Celyad's innovative platform focuses on creating treatments for both solid and hematologic tumors through advanced cell engineering techniques. The company develops both autologous and allogeneic CAR-T therapies that are currently undergoing clinical trials for conditions including acute myeloid leukemia and metastatic colorectal cancer. As a publicly traded company, Celyad is listed on multiple exchanges including Euronext Brussels, Euronext Paris, and the Nasdaq Global Market under the ticker symbol CYAD.Explore more
Celyad's Social MediaPopular SearchesCelyad Oncology SACelyad IncCelyad SACelyadCelyad OncologySIC Code 28,283NAICS Code 32,325Ticker NASDAQ: CYADShow more

Is Celyad your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Celyad is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Celyad is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Celyad.

Celyad financials insights

Gather financial insights about Celyad, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2009

Series B

$8.1M

2015

Stock Offering

$100.1M

2021

Share Placement

$40M

Share Placement

$32.5M

See All Celyad's Financials Insights

Celyad Tech Stack

A closer look at the technologies used by Celyad

Most Recent Scoops

Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
Event
Events
New Hire
Executive Move
See more scoops

Top Manufacturing Companies

Frequently Asked Questions Regarding Celyad

What is Celyad's stock symbol?
Celyad's stock symbol is CYAD
What is Celyad's official website?
Celyad's official website is www.celyad.com
What is Celyad's Revenue?
Celyad's revenue is <$5 Million
What is Celyad's SIC code?
Celyad's SIC: 28,283
What is Celyad's NAICS code?
Celyad's NAICS: 32,325
How many employees does Celyad have?
Celyad has 11-50 employees
What industry does Celyad belong to?
Celyad is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What technology does Celyad use?
Some of the popular technologies that Celyad uses are: WordPress.org, reCAPTCHA, PHP, Bullhorn
How do I contact Celyad?
Celyad contact info: Phone number: +32 10394100 Website: www.celyad.com
What does Celyad do?

Celyad is a clinical-stage biopharmaceutical company founded in 2007 and headquartered in Mont-Saint-Guibert, Belgium, with additional operations in New York. The company specializes in the development of CAR-T cell-based therapies targeting cancer. Celyad's innovative platform focuses on creating treatments for both solid and hematologic tumors th... rough advanced cell engineering techniques. The company develops both autologous and allogeneic CAR-T therapies that are currently undergoing clinical trials for conditions including acute myeloid leukemia and metastatic colorectal cancer. As a publicly traded company, Celyad is listed on multiple exchanges including Euronext Brussels, Euronext Paris, and the Nasdaq Global Market under the ticker symbol CYAD.Read More

What are Celyad social media links?
Celyad Linkedin page Celyad Twitter page
Who invested in Celyad?
Celyad has 7 investors including Grifols, Life Sciences Research Partners, Hunza Ventures SCA Hunza Ventures and Sriw.
Is Celyad a public company?
Yes, Celyad is a public company and is traded under the symbol CYAD
See more information about Celyad

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.